Author
Eduardas Aleknavičius
Also Known As
Aleknavičius, Eduardas, E Aleknavicius, E Aleknavičius, E. Aleknavicius, E. Aleknavičius, Eduardas Aleknavicius, Eduardas Aleknavičius, K. Rashid
70
Publications
2.4K
Citations
12
H-Index
20
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 4 | 4 | 1.8K |
2 | Pathology | 4 | 4 | 1.8K |
3 | Immunology | 1 | 1 | 21 |
4 | Rheumatology | 1 | 1 | 21 |
5 | Surgical Oncology | 1 | 1 | 12 |
Eduardas Aleknavičius
×
14
Publications
2K
Citations
12
H-Index
| Year | Citations | |
|---|---|---|
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau, MedicinePathologyHead And Neck CancerCancer TreatmentNeck Oncology | 2018 | 1.6K |
2019 | 111 | |
2013 | 59 | |
2017 | 47 | |
2007 | 39 | |
2008 | 38 | |
2016 | 22 | |
2011 | 21 | |
2014 | 14 | |
2013 | 12 |
Page 1
Page 1